TMDX - TransMedics Group, Inc.
NEXT EARNINGS:
May 5, 2026
EPS Est: $0.70
|
Rev Est: $171.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$148.17
DETAILS
HIGH:
$166.00
LOW:
$135.00
MEDIAN:
$146.50
CONSENSUS:
$148.17
UPSIDE:
7.54%
Market Cap:
4.71B
Volume:
1,152,495
Avg Volume:
724,280
52 Week Range:
62.073-156
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.98
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
728
IPO Date:
2019-05-02
EPS (TTM):
1.07
P/E Ratio:
21.73
Revenue (TTM):
441.54M
Total Assets:
804.08M
Total Debt:
518.29M
Cash & Equiv:
336.65M
Rev Growth (5Y):
79.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
6.7%
Debt/Equity:
2.27
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-24 | $2.57 | $0.41 | +526.8% | $160.8M | $155.3M | +3.5% |
| 2025-10-29 | $0.66 | $0.37 | +78.4% | $143.8M | $155.4M | -7.5% |
| 2025-07-30 | $0.92 | $0.48 | +91.7% | $157.4M | $141.6M | +11.1% |
| 2025-05-08 | $0.70 | $0.29 | +141.4% | $143.5M | $123.4M | +16.3% |
| 2025-02-27 | $0.19 | $0.22 | -13.6% | $121.6M | $109.5M | +11.1% |
| 2024-10-28 | $0.12 | $0.29 | -58.6% | $108.8M | $112.2M | -3.0% |
| 2024-07-31 | $0.35 | $0.21 | +66.7% | $114.3M | $114.1M | +0.2% |
| 2024-04-30 | $0.35 | $0.03 | +974.9% | $96.8M | $83.9M | +15.4% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 441.54M | 241.62M | 93.46M | 30.26M | 25.64M | 23.60M | 13.02M | 7.68M | 6.21M |
| Net Income | 35.46M | (25.03M) | (36.23M) | (44.22M) | (28.75M) | (33.55M) | (23.76M) | (20.82M) | (24.07M) |
| EPS | 1.07 | -0.77 | -1.23 | -1.60 | -1.16 | -2.36 | -1.23 | -1.44 | -1.66 |
| Total Assets | 804.08M | 706.05M | 277.15M | 134.89M | 152.03M | 105.30M | 42.16M | 37.00M | 58.10M |
| Total Debt | 518.29M | 515.95M | 67.56M | 43.80M | 34.66M | 34.15M | 33.67M | 8.65M | 8.41M |
| Cash & Equivalents | 336.65M | 394.81M | 201.18M | 25.58M | 24.58M | 20.09M | 20.24M | 11.94M | 9.84M |
| Operating Cash Flow | 48.80M | (13.03M) | (45.82M) | (28.86M) | (30.27M) | (32.29M) | (25.98M) | (23.10M) | (24.11M) |
| Free Cash Flow | (80.94M) | (192.09M) | (57.72M) | (32.38M) | (30.72M) | (32.45M) | (26.40M) | (23.36M) | (25.59M) |
| FCF per Share | -2.44 | -5.91 | -1.95 | -1.17 | -1.24 | -2.28 | -1.37 | -1.61 | -1.77 |
| Book Value | 228.60M | 137.20M | 187.38M | 67.85M | 103.89M | 54.65M | (4.83M) | (168.72M) | 38.79M |
| Cash & ST Investments | 336.65M | 394.81M | 201.18M | 92.45M | 125.64M | 80.69M | 20.24M | 24.66M | 47.84M |
| ROC Equity | 0.16 | -0.18 | -0.19 | -0.65 | -0.28 | -0.61 | N/A | N/A | -0.62 |